BRPI0810192A2 - Aspartato do ácido 1-ciclopropil-6-fluoro-7-(8-metoxiimino-2,6-diazaespir o [3,4] oct-6-il)-4-oxo-1,4-diidro- [1,8] naftiridina-3-carboxílico, método para preparação do mesmo e composição farmacêutica antimicrobiana compreendendo o mesmo. - Google Patents

Aspartato do ácido 1-ciclopropil-6-fluoro-7-(8-metoxiimino-2,6-diazaespir o [3,4] oct-6-il)-4-oxo-1,4-diidro- [1,8] naftiridina-3-carboxílico, método para preparação do mesmo e composição farmacêutica antimicrobiana compreendendo o mesmo.

Info

Publication number
BRPI0810192A2
BRPI0810192A2 BRPI0810192-2A2A BRPI0810192A BRPI0810192A2 BR PI0810192 A2 BRPI0810192 A2 BR PI0810192A2 BR PI0810192 A BRPI0810192 A BR PI0810192A BR PI0810192 A2 BRPI0810192 A2 BR PI0810192A2
Authority
BR
Brazil
Prior art keywords
diazepyr
methoxyimin
antimicrobian
naphthridine
aspartate
Prior art date
Application number
BRPI0810192-2A2A
Other languages
English (en)
Inventor
Jei Man Ryu
Dong Rack Choi
Jin Yang
Sue Hye Yoon
Seung Hwan Kim
Sae Kwang Ku
Original Assignee
Dong Wha Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong Wha Pharm Ind Co Ltd filed Critical Dong Wha Pharm Ind Co Ltd
Publication of BRPI0810192A2 publication Critical patent/BRPI0810192A2/pt
Publication of BRPI0810192B1 publication Critical patent/BRPI0810192B1/pt
Publication of BRPI0810192B8 publication Critical patent/BRPI0810192B8/pt
Publication of BRPI0810192C1 publication Critical patent/BRPI0810192C1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
BRPI0810192A 2007-04-13 2008-04-14 aspartato do ácido 1-ciclopropil-6-fluoro-7-(8-metoxiimino-2,6-diaza-espiro [3,4] oct-6-il)-4-oxo-1,4-diidro- [1,8] naftiridina-3-carboxílico, método para preparação do mesmo e composição farmacêutica antimicrobiana compreendendo o mesmo. BRPI0810192C1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20070036574 2007-04-13
PCT/KR2008/002106 WO2008127060A1 (en) 2007-04-13 2008-04-14 Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same

Publications (4)

Publication Number Publication Date
BRPI0810192A2 true BRPI0810192A2 (pt) 2014-12-30
BRPI0810192B1 BRPI0810192B1 (pt) 2019-09-03
BRPI0810192B8 BRPI0810192B8 (pt) 2019-09-10
BRPI0810192C1 BRPI0810192C1 (pt) 2021-05-25

Family

ID=39864109

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810192A BRPI0810192C1 (pt) 2007-04-13 2008-04-14 aspartato do ácido 1-ciclopropil-6-fluoro-7-(8-metoxiimino-2,6-diaza-espiro [3,4] oct-6-il)-4-oxo-1,4-diidro- [1,8] naftiridina-3-carboxílico, método para preparação do mesmo e composição farmacêutica antimicrobiana compreendendo o mesmo.

Country Status (16)

Country Link
US (1) US8324238B2 (pt)
EP (1) EP2134712B1 (pt)
JP (1) JP5194105B2 (pt)
KR (1) KR100953271B1 (pt)
CN (1) CN101679416B (pt)
AU (1) AU2008239966C1 (pt)
BR (1) BRPI0810192C1 (pt)
CA (1) CA2683939C (pt)
CO (1) CO6251358A2 (pt)
DK (1) DK2134712T3 (pt)
EC (1) ECSP099736A (pt)
ES (1) ES2436140T3 (pt)
MX (1) MX2009011063A (pt)
PL (1) PL2134712T3 (pt)
PT (1) PT2134712E (pt)
WO (1) WO2008127060A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080109108A (ko) 2007-06-12 2008-12-17 (주)엘티엠에이피 휴대단말기용 스텝 힌지
KR101468659B1 (ko) 2009-07-27 2014-12-05 주식회사 아리바이오 Ｒ-7-(3-아미노메틸-4-메톡시이미노-3-메틸-피롤리딘-1-일)-1-시클로프로필-6-플루오로-4-옥소-1,4-디히드로-[1,8]나프티리딘-3-카르복실산 ｌ-아스파르트산염, 이의 제조방법 및 이를 포함하는 항균용 약학적 조성물
KR101646324B1 (ko) * 2014-03-04 2016-08-05 동화약품주식회사 1-시클로프로필-6-플루오로-7-(8-메톡시이미노-2,6-디아자-스피로[3,4]옥트-6-일)-4-옥소-1,4-디히드로-[1,8]나프티리딘-3-카르복실산 디-아스파르트산염의 수화물 및 이를 포함하는 항균활성 조성물
CN103922987B (zh) * 2014-05-04 2016-09-28 苏州天马精细化学品股份有限公司 一种扎布沙星中间体及其合成方法
KR102213991B1 (ko) * 2014-05-20 2021-02-09 동화약품주식회사 개선된 자보플록사신의 제조방법
CN114894924B (zh) * 2022-04-21 2024-06-21 徐州医科大学 一种通过非衍生化gc-ms同时测定人血浆中4种抗癫痫药物的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8304117A1 (es) 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
ZA824096B (en) * 1981-06-11 1983-04-27 Warner Lambert Co Salts of antimicrobial naphthyridine and quinoline compounds
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
KR960000223A (ko) * 1994-06-08 1996-01-25 김정순 신규한 피리돈 카르복실산 화합물을 함유한 수용액 및 이의 제조방법
JP3280388B2 (ja) * 1997-06-26 2002-05-13 ドング ホワ ファーマシューチカル インダストリアル カンパニー，リミテッド キノロンカルボン酸誘導体
AU776732B2 (en) 1999-10-04 2004-09-23 John Carter Pharmaceutical compositions containing copper, salicylic acid and vitamines C
HRP20040940A2 (en) * 2002-04-08 2005-04-30 Pfizer Inc. Tropane derivatives as ccr5 modulators

Also Published As

Publication number Publication date
BRPI0810192C1 (pt) 2021-05-25
PL2134712T3 (pl) 2014-01-31
KR20080092893A (ko) 2008-10-16
CA2683939C (en) 2012-06-19
KR100953271B1 (ko) 2010-04-16
JP2010523649A (ja) 2010-07-15
CA2683939A1 (en) 2008-10-23
EP2134712A4 (en) 2011-07-27
AU2008239966B2 (en) 2011-11-10
DK2134712T3 (da) 2013-11-18
EP2134712B1 (en) 2013-08-21
US8324238B2 (en) 2012-12-04
AU2008239966A1 (en) 2008-10-23
AU2008239966C1 (en) 2012-03-29
BRPI0810192B8 (pt) 2019-09-10
HK1133881A1 (en) 2010-04-09
CN101679416A (zh) 2010-03-24
CN101679416B (zh) 2012-06-27
JP5194105B2 (ja) 2013-05-08
MX2009011063A (es) 2009-10-30
US20100184795A1 (en) 2010-07-22
CO6251358A2 (es) 2011-02-21
PT2134712E (pt) 2013-11-26
WO2008127060A1 (en) 2008-10-23
ES2436140T3 (es) 2013-12-27
BRPI0810192B1 (pt) 2019-09-03
ECSP099736A (es) 2010-02-26
EP2134712A1 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
BRPI0718688A2 (pt) Composições de baixa irritação e métodos para preparar as mesmas.
IL195528A (en) Pyridazine compound, methods of preparation, a pharmaceutical composition containing it, its use and intermediate material
IL195813A0 (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
IL192967A0 (en) Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
IL185353A0 (en) Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof
IL204844A (en) Coinolone analogues, pharmaceuticals containing them and their uses
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
EP1984370A4 (en) PROTEIN KINASE ACTIVITY INHIBITING IMIDAZOPYRIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
IL177533A (en) Benzimidazole derivatives, their preparation and pharmaceutical compositions comprising them
IL195488A (en) Compounds, pharmaceuticals containing them and their uses
IL225207A (en) A derivative of multi-ring carbamoylpyridone, its pharmaceutical composition, its use and its preparation
PL2364983T3 (pl) Nowa pochodna tricykliczna lub jej farmaceutycznie dopuszczalne sole, sposób jej wytwarzania, oraz zawierająca ją kompozycja farmaceutyczna
ZA200810481B (en) Benzimidazole derivatives, method for the production thereof, their use as FXR agonists and pharmaceutical preparations containing the same
IL204621A0 (en) Bicyclic - ?? - amino acid derivatives, compositions comprising the same and uses thereof
IL206808A (en) Indolyl-pyridone history, their pharmaceutical preparations and their uses
EP2023926A4 (en) PYRIDONECARBOXAMIDE DERIVATIVES USEFUL FOR TREATING HYPERPROLIFERATIVE AND ANGIOGENESIS RELATED DISORDERS
BRPI0815057A2 (pt) Composto, composição farmacêutica, e, método para tratar infecção.
IL200206A (en) The history of quinaxaline, their preparation and their pharmaceutical preparations
EP2086317A4 (en) NICOTINE FORMULATIONS, KITS AND SYSTEMS AND METHOD FOR THEIR USE
IL187235A0 (en) 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament
EP2269653A4 (en) COMPOSITION FOR THE STABILIZATION OF BLOCKER AND THE COMPOSITION COMPRISING TRANSDERMAL ABSORBABLE PREPARATION
ZA200700397B (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
ZA200900237B (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
EP2208732A4 (en) DEHYDROXYLATED VANCOMYCIN, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
IL186062A0 (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/09/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/09/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/09/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) REFERENTE A RPI 2539 DE 03/09/2019,QUANTO AO ITEM (43) DATA DA PUBLICACAO DO PEDIDO.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/04/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2718 DE 07/02/2023 POR TER SIDO INDEVIDA.